Aptose Biosciences Inc (NASDAQ:APTO)’s traded shares stood at 0.86 million during the last session, with the company’s beta value hitting 0.93. At the close of trading, the stock’s price was $0.19, to imply an increase of 0.52% or $0.0 in intraday trading. The APTO share’s 52-week high remains $2.91, putting it -1431.58% down since that peak but still an impressive 31.58% since price per share fell to its 52-week low of $0.13. The company has a valuation of $11.60M, with an average of 2.04 million shares in intraday trading volume over the past 10 days and average of 430.99K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Aptose Biosciences Inc (APTO), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give APTO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.35.
Aptose Biosciences Inc (NASDAQ:APTO) trade information
After registering a 0.52% upside in the last session, Aptose Biosciences Inc (APTO) has traded red over the past five days. The 5-day price performance for the stock is 7.03%, and -51.23% over 30 days. With these gigs, the year-to-date price performance is -92.33%. Short interest in Aptose Biosciences Inc (NASDAQ:APTO) saw shorts transact 0.12 million shares and set a 1.61 days time to cover.
Aptose Biosciences Inc (APTO) estimates and forecasts
Looking at statistics comparing Aptose Biosciences Inc share performance against respective industry, we note that the company has outperformed competitors. Aptose Biosciences Inc (APTO) shares are -78.82% down over the last 6 months, with its year-to-date growth rate higher than industry average at 76.39% against 17.50%.
APTO Dividends
Aptose Biosciences Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
Aptose Biosciences Inc insiders hold 16.39% of total outstanding shares, with institutional holders owning 16.68% of the shares at 19.96% float percentage. In total, 16.68% institutions holds shares in the company, led by DOHENY ASSET MANAGEMENT /CA. As of 2024-06-30, the company held over 50550.0 shares (or 0.3849% of shares), all amounting to roughly $0.32 million.
The next major institution holding the largest number of shares is CALDWELL SUTTER CAPITAL, INC. with 92.0 shares, or about 0.0007% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $70.0.
